Julius F. Remenar,Laura Cook Blumberg,Tarek A. Zeidan
申请号:
US16425119
公开号:
US20190276406A1
申请日:
2019.05.29
申请国别(地区):
US
年份:
2019
代理人:
摘要:
Lactam compounds of Formula I and their use for the treatment of neurological and psychiatric disorders including schizophrenia, bipolar disorder, anxiety disorder and insomnia is disclosed.